Pinz Capital Management’s Twist Bioscience TWST Stock Holding History

Pinz Capital Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16,050	Closed	-$2.27M	–	369
2020 Q4	$2.27M	Buy	+16,050	New	+$1.78M	1.03%	43
2020 Q3	–	Sell	-54,800	Closed	-$2.48M	–	180
2020 Q2	$2.48M	Sell	54,800 -25,300	-32%	-$908K	1.14%	28
2020 Q1	$2.45M	Buy	+80,100	New	+$2.15M	6.42%	4

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Pinz Capital Management's TWST Position: Q1 2021 in Review

Pinz Capital Management sold out of Twist Bioscience (TWST) in Q1 2021, closing a stake of 16,050 shares — an estimated $2.27M sold.

Pinz Capital Management first reported a position in TWST in Q1 2020 and held it in 3 quarters. The position peaked at $2.48M in Q2 2020. 239 funds tracked by Wall St. Rank hold TWST as of Q1 2021.

Pinz Capital Management reported no remaining Twist Bioscience position as of Q1 2021 after selling out during the quarter.
Pinz Capital Management sold 16,050 Twist Bioscience shares in Q1 2021, an estimated $2.27M.
Pinz Capital Management first reported a position in Twist Bioscience in Q1 2020 and held it in 3 quarters.
Pinz Capital Management's Twist Bioscience position peaked at $2.48M in Q2 2020.
239 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2021.

Based on Pinz Capital Management's 13F filing for Q1 2021, filed 17 May 2021.